Coleus Forskohlii (Forskolin) for Asthma Support

Research suggests that the available published evidence directly supporting forskolin for asthma is extremely limited, and the single linked study does not actually investigate asthma outcomes at all. Studies indicate that this particular animal study examined blood glucose regulation and oxidative stress markers in rats, finding that forskolin reduced fasting blood sugar in both healthy and diabetic animals, though antioxidant effects did not reach statistical significance. While forskolin has a theoretical basis for potential respiratory benefit rooted in its ability to raise cellular cyclic AMP levels, which is a mechanism also targeted by some bronchodilator medications, this mechanistic rationale is not reflected in the studies provided here. Readers interested in the asthma-specific evidence base should note that the current linked literature does not support drawing conclusions about forskolin's effectiveness for asthma support.